Compare BLX & AORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BLX | AORT |
|---|---|---|
| Founded | 1977 | 1984 |
| Country | Panama | United States |
| Employees | N/A | N/A |
| Industry | Commercial Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | 1997 | 1996 |
| Metric | BLX | AORT |
|---|---|---|
| Price | $48.19 | $36.39 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $48.76 |
| AVG Volume (30 Days) | 108.3K | ★ 483.0K |
| Earning Date | 01-01-0001 | 05-15-2026 |
| Dividend Yield | ★ 5.73% | N/A |
| EPS Growth | N/A | ★ 165.62 |
| EPS | N/A | ★ 0.21 |
| Revenue | N/A | ★ $298,836,000.00 |
| Revenue This Year | $13.11 | $14.20 |
| Revenue Next Year | $10.13 | $11.17 |
| P/E Ratio | ★ $8.26 | $172.29 |
| Revenue Growth | N/A | ★ 18.01 |
| 52 Week Low | $31.14 | $21.97 |
| 52 Week High | $51.99 | $48.25 |
| Indicator | BLX | AORT |
|---|---|---|
| Relative Strength Index (RSI) | 45.44 | 36.94 |
| Support Level | $43.50 | $34.35 |
| Resistance Level | $51.60 | $44.29 |
| Average True Range (ATR) | 1.12 | 1.48 |
| MACD | -0.33 | 0.03 |
| Stochastic Oscillator | 33.62 | 33.85 |
Banco Latinoamericano de Comercio Exterior SA provides financial solutions to financial institutions, companies, and investors doing business in Latin America, supporting trade and regional integration. The Bank provides foreign trade solutions to a select client base of American financial institutions and corporations and has developed a network of correspondent banking institutions with access to the international capital markets. It has two business segments: the Commercial Business Segment and the Treasury Business Segment. The majority of its revenue is generated from the Commercial Business segment.
Artivion Inc offers cardiac and vascular surgeons a suite of aortic-centric solutions. The company's products include Aortic Heart Valve, Mitral Heart Valve, Aortic Allograft, Pulmonary Human Heart Valve, Pulmonary Patch, and Surgical Adhesive among others. The company's has two reportable segments: Medical Devices and Preservation Services. The Medical Devices segment includes revenues from sales of aortic stent grafts, surgical sealants, On-X products, and other product revenues. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues. Company operates in North America, EMEA. LATAM, APAC. Maximum revenue is from North America.